[1]
N. Awad, N. Yassen, A. Tawfeeq, and K. Turki, “Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line”, J Fac Med Bagdad, vol. 57, no. 4, pp. 320-324, Jan. 2016.